Bruce Thiers to Adult
This is a "connection" page, showing publications Bruce Thiers has written about Adult.
Connection Strength
0.131
-
Cutaneous blastomycosis: a diagnostic challenge. Int J Dermatol. 2008 Aug; 47(8):824-30.
Score: 0.022
-
Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases. J Am Acad Dermatol. 2021 07; 85(1):46-55.
Score: 0.013
-
The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries. J Am Acad Dermatol. 2020 Oct; 83(4):1118-1129.
Score: 0.012
-
Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries. J Am Acad Dermatol. 2020 08; 83(2):486-492.
Score: 0.012
-
Systemic Weber-Christian disease. J Cutan Med Surg. 2000 Apr; 4(2):110-2.
Score: 0.012
-
A cohort study of personal and family history of skin cancer in relation to future risk of non-cutaneous malignancies. Cancer Causes Control. 2019 Nov; 30(11):1213-1221.
Score: 0.012
-
Keratinocyte Carcinoma and Risk for Another Type of Cancer: Assessment of a Dose-response Relationship. Anticancer Res. 2019 Sep; 39(9):5083-5087.
Score: 0.012
-
High Levels of Gadolinium Deposition in the Skin of a Patient With Normal Renal Function. Invest Radiol. 2016 May; 51(5):280-9.
Score: 0.009
-
Automatic diagnosis of melanoma using machine learning methods on a spectroscopic system. BMC Med Imaging. 2014 Oct 13; 14:36.
Score: 0.008
-
Topical steroid therapy of atopic skin diseases. Allergy Proc. 1989 Nov-Dec; 10(6):413-6.
Score: 0.006
-
The effect of aging and chronic sun exposure on human Langerhans cell populations. J Invest Dermatol. 1984 Mar; 82(3):223-6.
Score: 0.004
-
Therapeutic briefs. I. J Am Acad Dermatol. 1980 Nov; 3(5):533-7.
Score: 0.003
-
Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail. J Am Acad Dermatol. 1998 Jun; 38(6 Pt 2):S95-102.
Score: 0.003
-
A randomized double-blind study of inosiplex (isoprinosine) therapy in patients with alopecia totalis. J Am Acad Dermatol. 1987 May; 16(5 Pt 1):977-83.
Score: 0.001
-
An open-label trial of immunomodulation therapy with inosiplex (Isoprinosine) in patients with alopecia totalis and cell-mediated immunodeficiency. J Am Acad Dermatol. 1984 Aug; 11(2 Pt 1):224-30.
Score: 0.001
-
Immunological profiles in alopecia areata. Br J Dermatol. 1984 Feb; 110(2):163-70.
Score: 0.001